The rise of a ribosomopathy and increased cancer risk Friedrich Luft Clinical Implications 12 December 2009 Pages: 1 - 3
Modulation of bone marrow stromal cell functions in infectious diseases by toll-like receptor ligands Krisztian NemethBalazs MayerEva Mezey Review 13 September 2009 Pages: 5 - 10
MACC1 — more than metastasis? Facts and predictions about a novel gene Ulrike SteinMathias DahlmannWolfgang Walther Review 30 September 2009 Pages: 11 - 18
T cell cross-talk with kidney dendritic cells in glomerulonephritis Ulf PanzerChristian Kurts Review 02 October 2009 Pages: 19 - 26
Regulation of type 1 diabetes, tuberculosis, and asthma by parasites Zhugong LiuQian LiuWilliam C. Gause Review 21 October 2009 Pages: 27 - 38
Cooperative effect of ribosomal protein s19 and Pim-1 kinase on murine c-Myc expression and myeloid/erythroid cellularity Anne-Sophie FröjmarkJitendra BadhaiNiklas Dahl Original Article 08 November 2009 Pages: 39 - 46
The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle Lin PiaoYong-Hu FangStephen L. Archer Original Article 01 December 2009 Pages: 47 - 60
Fine mapping of Plasmodium falciparum ribosomal phosphoprotein PfP0 revealed sequences with highly specific binding activity to human red blood cells Gabriela Arevalo-PinzonHernando CurtidorManuel E. Patarroyo Original Article 21 September 2009 Pages: 61 - 74
Increased type IIA secretory phospholipase A2 expression contributes to oxidative stress in end-stage renal disease Markus van der GietMarkus TölleUwe J. F. Tietge Original Article 02 October 2009 Pages: 75 - 83
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia Giovanni MantovaniAntonio MacciòFilomena Panzone Original Article 03 October 2009 Pages: 85 - 92